ZOETIS INC.

ZTSNYSE

Healthcare · Pharmaceutical Preparations

Market cap

$32.57B

Employees

14,500

Exchange

NYSE

Headquarters

PARSIPPANY, NJ

About ZOETIS INC.

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Industry

Pharmaceutical Preparations

Sector

Healthcare

Country

Website

www.zoetis.com

ZTS news

ZTS Class Action Reminder - Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Zoetis Inc. Class Acton Lawsuit

GlobeNewswire Inc. · Jun 1, 2026

ZTS INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Zoetis Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

GlobeNewswire Inc. · May 30, 2026

Levi & Korsinsky Announces Investigation of Securities Claims Against Zoetis (ZTS)

Law firm Levi & Korsinsky has initiated an investigation into potential securities law violations by Zoetis Inc., a leading animal health company. The investigation examines whether the company made misleading statements or omitted material information that affected investor decisions. Shareholders who suffered losses may be eligible to participate in legal proceedings.

GlobeNewswire Inc. · May 21, 2026

View full ZTS analysis →